Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C16orf46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLIN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G2E3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO11-LRRC70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMP2K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IL13RA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNPNAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPY30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C5orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUCLA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FHL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR1OP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on